Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs (PDF)

Name: Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs
Brand: Springer-Verlag GmbH
SKU: 102869269
Price: 153.99 EUR
Availability: OnlineOnly

Cell Signaling Pathways and microRNAs in Cancer Biology (Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 153.99 €

Buch (Gebunden) 164.99 €

sofort als Download lieferbar

Bestellnummer: 102869269

Printausgabe 164.99 €

eBook (pdf) -7% 153.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs (PDF)“

Cancer is a multifaceted disease and overwhelmingly increasing experimental evidence has helped us to develop a deeper understanding of the role of signal transduction cascades in cancer development and progression. Tissue microarrays and next generation sequencing technologies have assisted us to gather missing pieces of jigsaw puzzle and we now know that deregulation of spatio-temporally controlled signaling cascades play fundamental role in metastasis and resistance against wide ranging therapeutics.

This book offers a balanced overview of the rapidly emerging cutting edge research in molecular oncology and good source of knowledge for established oncologists, basic and medical students and pharmaceutical industry associated R&D departments.

Autoren-Porträt

Sundas Fayyaz is working as a Scientist in research laboratory of Rashid Latif Medical College (RLMC). Her expertise lies in cancer genetics and therapeutics.
Ammad Ahmad Farooqi is currently a Senior Scientist at the Institute of Biomedical and Genetic Engineering (IBGE), in Islamabad, Pakistan. His area of research is tightly focused on cancer genetics and therapeutics.